FAB subtype distribution of AML with 11q23/MLL rearrangement compared with the total AML cohort
. | Total cohort, n (%) . | MLL rearrangement, n (%) . |
|---|---|---|
| Total | 1897 | 54 |
| No data on FAB subtype | 407 | 2 |
| Data on FAB subtype | 1490 (100) | 52 (100) |
| M0 | 63 (4.2) | 1 (1.9) |
| M1 | 221 (14.8) | 4 (7.7) |
| M2 | 538 (36.1) | 5 (9.6) |
| M3 | 75 (5.0) | — |
| M3v | 30 (2.0) | — |
| M4 | 260 (17.4) | 11 (21.2) |
| M4eo | 85 (5.7) | — |
| M5a | 71 (4.8) | 20 (38.5) |
| M5b | 82 (5.5) | 11 (21.2) |
| M6 | 53 (3.6) | — |
| M7 | 12 (0.8) | — |
. | Total cohort, n (%) . | MLL rearrangement, n (%) . |
|---|---|---|
| Total | 1897 | 54 |
| No data on FAB subtype | 407 | 2 |
| Data on FAB subtype | 1490 (100) | 52 (100) |
| M0 | 63 (4.2) | 1 (1.9) |
| M1 | 221 (14.8) | 4 (7.7) |
| M2 | 538 (36.1) | 5 (9.6) |
| M3 | 75 (5.0) | — |
| M3v | 30 (2.0) | — |
| M4 | 260 (17.4) | 11 (21.2) |
| M4eo | 85 (5.7) | — |
| M5a | 71 (4.8) | 20 (38.5) |
| M5b | 82 (5.5) | 11 (21.2) |
| M6 | 53 (3.6) | — |
| M7 | 12 (0.8) | — |
—indicates no care.